Bristol Myers Squibb Announces Strategic Agreement with Anthropic to Position Claude Enterprise as the Shared Intelligence Platform Across Its Global Operations Life Science Investing
Pfizer Advances Pivotal Pediatric Pneumococcal Vaccine Program Following Strong Positive Phase 2 Results Pharmaceutical Investing
Journey Medical Corporation to Participate in A.G.P.'s Annual Virtual Healthcare Conference Life Science Investing
Eton Pharmaceuticals Expands Rare Disease Portfolio Through Agreement for U.S. Commercialization Rights to IMPAVIDO® Life Science Investing
NurExone Receives Notice of Patent Grant in South Korea Covering ExoPTEN Technology Life Science Investing
Aurinia Pharmaceuticals Completes Successful Tender Offer for Kezar Life Sciences Life Science Investing
Minerva Neurosciences to Participate in the 2026 Jefferies Global Healthcare Conference Pharmaceutical Investing
CytomX Therapeutics Appoints Mamata Gokhale, Ph.D., RAC, as Senior Vice President of Regulatory Affairs Life Science Investing
Gossamer Bio, Inc. Launches Exchange Offer and Consent Solicitation Intended to Eliminate Over $120 Million of Debt with Existing Noteholder Support Life Science Investing
Gossamer Bio Announces First Quarter 2026 Financial Results and Provides Business Update Life Science Investing
